Skip to main content
Caplight Logo









Myrtelle Inc.

Myrtelle Inc.

Private
New York City, New YorkHealthcare & Life Scienceshttps://myrtellegtx.com/

Last Round

Early Stage

VC

Jul 2, 2026

Total Funding Raised

$83.67M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Myrtelle Inc. is a biotechnology company that develops and delivers novel gene therapy treatments for devastating disorders of the central nervous system.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyrAAVCanavan diseasegenetic medicineoligodendrocyte targetingviral vectorbiotechrare disease treatmentneurodegenerative diseaseAAV capsid platformmyelin-based disordersclinical-stage biotechCDMOorphan drugprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myrtelle Inc. Comparables

Compare Myrtelle Inc. with similar companies based on industry and business-model similarity.

Myrtelle Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BridgeBio
83%
Capsida Biotherapeutics
78%
Ajinomoto Co. Inc
78%

Myrtelle Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCJul 2, 2026
Series CDec 23, 2025
DebtMar 11, 2025
DebtJun 7, 2024
Series BDec 1, 2022
Series A
Jul 8, 2021

Key People

Founding team and executive leadership

Adrian Stecyk

CEO, Co-Founder

Founding Team

Myrtelle Inc. Investors

Notable investors and investment history

Myrtelle Inc. investors
InvestorRounds
Panacea Venture HealthcareSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2026

    $17M raised in early stage VC round.

Recent news

Latest coverage and updates

  • is_developingSep 22, 2026

    Myrtelle, Inc. is developing MYR-103 on Jul 1st '26.

Myrtelle Inc. Filings

Explore SEC and related filing metadata, where available.

Myrtelle Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Myrtelle Inc.'s valuation, stock price, and market status.

Is Myrtelle Inc. a public or private company?

Myrtelle Inc. is a private company.

What is the current stock price of Myrtelle Inc.?

Myrtelle Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Myrtelle Inc. worth (valuation)?

Valuation information for Myrtelle Inc. is not publicly available.

Can I buy Myrtelle Inc. stock?

Myrtelle Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Myrtelle Inc.'s last funding round?

Myrtelle Inc.'s most recent funding round was Early Stage VC on July 2, 2026.

Who are the main investors in Myrtelle Inc.?

Investor information for Myrtelle Inc. is not publicly disclosed.

Will Myrtelle Inc. IPO soon?

No public IPO plans have been announced for Myrtelle Inc..

How can I track Myrtelle Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Myrtelle Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range11
Year Founded2020
Last FundingJul 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?